|
|
Validation of an Automated Screening Platform in Zebrafish
|
|
Date added: 05/27/2009 |
|
O. Holgado, C. Callol, J.M. Virto, I. Ibarbia et al. Validation of an Automated Screening Platform in Zebrafish (2009). Screening Europe 2009. |
|
|
|
|
|
|
Prediction of Hepatotoxicity in Zebrafish
|
|
Date added: 08/19/2010 |
|
O. Holgado, M.Diez, C. Callol-Massot, M. Luz Martínez-Chantar, A. Letamendia (2010). Prediction of Hepatotoxicity in Zebrafish. EUROTOX-IUTOX Barcelona 2010. |
|
|
|
|
|
|
Generation of Zebrafish Models for Cardiovascular Diseases_HTS Application
|
|
Date added: 08/21/2010 |
|
C. Callol-Massot, A. Muriana, A. Cruz, i. Ibarbia, A. Letamendia, J.C. Ispizua- Belmonte (2006). Generation of Zebrafish Models for Cardiovascular Diseases: HTS application. High Throughput Screening San Francisco, 2006. |
|
|
|
|
|
|
Generation of Zebrafish Models for Cardiovascular Diseases
|
|
Date added: 03/18/2009 |
|
C. Callol-Massot, A. Muriana, A. Letamendia, A. Cruz (2008). Generation of Zebrafish Models for Cardiovascular Diseases. Screening America 2008. |
|
|
|
|
|
|
DARENET A novel technological platform to promote the use of zebrafish model
|
|
Date added: 07/20/2009 |
|
M. A. Pardo, S. Rainieri, A. Muriana, C. Callol et al. (2009).DARENET: a novel technology platform to promote the use of zebrafish model. International Zebrafish Congress Rome 2009. |
|
|
|
|
|
|
Automated Analysis of Cardiotoxicity in Zebrafish
|
|
Date added: 03/18/2009 |
|
E. Luño, O. Holgado, a. Muriana, A. Letamendia, C. Callol-Massot (2009). Automated Analysis of Cardiotoxicity in Zebrafish. CHI World Pharmaceutical Congress 2009. |
|
|
|
